Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency

Suberoylanilide hydroxamic acid (SAHA) has been assessed in clinical trials as part of a “shock and kill” strategy to cure HIV-infected patients. While it was effective at inducing expression of HIV RNA (“shock”), treatment with SAHA did not result in a reduction of reservoir size (“kill”). We there...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antiviral Res
Autors principals: White, Cory H., Johnston, Harvey E., Moesker, Bastiaan, Manousopoulou, Antigoni, Margolis, David M., Richman, Douglas D., Spina, Celsa A., Garbis, Spiros D., Woelk, Christopher H., Beliakova-Bethell, Nadejda
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5606336/
https://ncbi.nlm.nih.gov/pubmed/26343910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.09.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars